OnKure expands with new laboratory for cancer-drug research
BOULDER — OnKure Inc. has expanded its workspace for its therapeutics division with the opening of a new research laboratory. The biopharmaceutical company will use the space to develop new treatments for cancer.
OnKure president and CEO Tony Piscopio said the lab space will enable the company to develop chemical synthesis techniques to be used in discovering new cancer treatments.
“We are thrilled to announce the opening of our new research laboratory and expansion of our in-house discovery capabilities in support of the Company’s rapid growth trajectory,” Piscopio said in a statement.
Piscopio cited the company’s fast growth and Boulder’s concentration of similar…
THIS ARTICLE IS FOR SUBSCRIBERS ONLY
Continue reading for less than $3 per week!
Get a month of award-winning local business news, trends and insights
Access award-winning content today!
Related Posts
-
Medical-device firm Boulder iQ has nearly doubled its Boulder footprint with the purchase of a…
-
Ticket sales soon will end for the Boulder Valley Real Estate Conference, scheduled for Nov.…
-
OnKure Inc., a Boulder precision oncology company, and California-based Reneo Pharmaceuticals Inc. have completed a…
-
Real estate professionals are eligible to earn seven continuing-education credits at the 17th annual Boulder…
